Growth Metrics

Uxin (UXIN) Current Deferred Revenue (2018 - 2021)

Historic Current Deferred Revenue for Uxin (UXIN) over the last 4 years, with Q1 2021 value amounting to $3.6 million.

  • Uxin's Current Deferred Revenue fell 4998.59% to $3.6 million in Q1 2021 from the same period last year, while for Mar 2021 it was $3.6 million, marking a year-over-year decrease of 4998.59%. This contributed to the annual value of $3.6 million for FY2021, which is 4998.59% down from last year.
  • According to the latest figures from Q1 2021, Uxin's Current Deferred Revenue is $3.6 million, which was down 4998.59% from $7.1 million recorded in Q1 2020.
  • Over the past 5 years, Uxin's Current Deferred Revenue peaked at $16.8 million during Q4 2018, and registered a low of $3.6 million during Q1 2021.
  • Over the past 4 years, Uxin's median Current Deferred Revenue value was $7.4 million (recorded in 2019), while the average stood at $8.8 million.
  • In the last 5 years, Uxin's Current Deferred Revenue plummeted by 5363.85% in 2019 and then crashed by 4998.59% in 2021.
  • Quarter analysis of 4 years shows Uxin's Current Deferred Revenue stood at $16.8 million in 2018, then crashed by 53.64% to $7.8 million in 2019, then dropped by 8.6% to $7.1 million in 2020, then crashed by 49.99% to $3.6 million in 2021.
  • Its Current Deferred Revenue stands at $3.6 million for Q1 2021, versus $7.1 million for Q1 2020 and $7.8 million for Q4 2019.